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Abstract
Background: Evidence on the effectiveness of low-cost, sustainable, biological vector-control tools for the Aedes
mosquitoes is limited. Therefore, the purpose of this trial is to estimate the impact of guppy fish (guppies), in
combination with the use of the larvicide pyriproxyfen (Sumilarv® 2MR), and Communication for Behavioral Impact
(COMBI) activities to reduce entomological indices in Cambodia.
Methods/design: In this cluster randomized controlled, superiority trial, 30 clusters comprising one or more villages
each (with approximately 170 households) will be allocated, in a 1:1:1 ratio, to receive either (1) three interventions
(guppies, Sumilarv® 2MR, and COMBI activities), (2) two interventions (guppies and COMBI activities), or (3) control
(standard vector control). Households will be invited to participate, and entomology surveys among 40 randomly
selected households per cluster will be carried out quarterly. The primary outcome will be the population density of
adult female Aedes mosquitoes (i.e., number per house) trapped using adult resting collections. Secondary outcome
measures will include the House Index, Container Index, Breteau Index, Pupae Per House, Pupae Per Person, mosquito
infection rate, guppy fish coverage, Sumilarv® 2MR coverage, and percentage of respondents with knowledge about
Aedes mosquitoes causing dengue. In the primary analysis, adult female Aedes density and mosquito infection rates will
be aggregated over follow-up time points to give a single rate per cluster. This will be analyzed by negative binomial
regression, yielding density ratios.
Discussion: This trial is expected to provide robust estimates of the intervention effect. A rigorous evaluation of these
vector-control interventions is vital to developing an evidence-based dengue control strategy and to help direct
government resources.
Trial registration: Current Controlled Trials, ID: ISRCTN85307778. Registered on 25 October 2015.
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Background
Dengue is one of the most rapidly spreading mosquito-
borne viral diseases in the world, and is caused by bites
of infected Aedes mosquitoes, principally Aedes aegypti
[1]. Dengue infection is a systemic and dynamic disease
with a wide clinical spectrum that includes both severe
and non-severe manifestations and in some cases can
lead to death [1]. With an estimated 3.6 billion people in
124 countries at risk of contracting the disease [2] and
390 million dengue infections occurring each year (of
which 96 million are clinically apparent) [3], the dengue
virus has become a leading cause of illness in the tropics
and subtropics [4]. Asia records 70% of the global dis-
ease burden due to dengue [3] and Cambodia has one of
the highest per-capita incidence rates in the region [5].
Identified in Cambodia in 1963 [6], a total of 194,726
dengue cases were reported to the National Dengue
Control Program (NDCP) between 1980 and 2008 [7].
Between 2003 and 2008, annual dengue incidence
ranged between 0.7 and 3.0 per 1000 persons, the cost
to society estimated at between US$3,327,284 and
US$14,429,513 [8]. Since most of this cost falls onto the
family, it is estimated that 67% of affected households
(HHs) fall into debt to pay for medical bills [9]. How-
ever, it is likely that the real number of cases and cost to
society is much greater, with some studies suggesting the
real case numbers are between 3.9 and 29.0 times higher
than those of the National Dengue Surveillance System
[10, 11].
Although a number of promising vaccine candidates
are in preclinical and clinical development [12], and
methods of genetic control of mosquitoes are being de-
veloped [13–15], they are years from operational roll-out
in Cambodia and are unlikely to provide universal pro-
tection. Without a cure or vaccine the most appropriate
dengue control measures are vector control and the
avoidance of mosquito bites. Several vector-control
methods have been studied in Cambodia including
chemical and biological substances (temephos, pyriprox-
yfen (PPF), and Bacillus thuringiensis israelensis (Bti))
[16–19], jar covers [20], and distribution of larvivorous
copepods and fish [21–23].
Past research
Ae. aegypti is highly anthropophilic (preference for hu-
man beings), endophilic (resting indoors), and endopha-
gic (preference for feeding indoors) [19]. This partially
explains why previous studies showed that household
water storage jars contained over 80% of Ae. aegypti
larvae in Cambodia, and why these jars became the main
target for dengue vector-control activities [20]. Since the
early 1990s, the NDCP has used the larvicide temephos
(distributed with brand name Abate®) to target large
(200–400 L) household water containers as the primary
means of vector control [19]. This has continued despite
susceptibility tests in 2001 showing resistance of Ae.
aegypti in urban Phnom Penh and incipient resistance in
a rural province in Cambodia [24]. An evaluation of the
effectiveness of temephos control programs to control
larvae in 2007 concluded that control strategies empha-
sizing the use of temephos should be reconsidered [19].
Although temephos was only distributed during the
rainy season, there were still containers found to be
positive for immature Aedes during the dry season; and
the program ignored discarded containers – which had
twice the number of larvae as water storage containers.
Khun and Manderson (2007) concluded that “continued
reliance on temephos creates financial and technical
problems, while its inappropriate distribution raises the
possibility of larvicide resistance [19].”
Following the success of Mesocyclops (a genus of cope-
pod crustaceans) programs in locally eliminating Aedes
mosquitoes in Vietnam [25–27], the Cambodian NDCP
implemented a 2-year Mesocyclops project in Kratie
province from 2002 to 2004, searching for an alternative
vector-control option [23]. Initial results showed a re-
duction in the Aedes population in the intervention area,
but by the end of the project larval densities in the inter-
vention area had increased by 62% from baseline. This
apparently lower effectiveness in Cambodia may be be-
cause Mesocyclops from the local water sources had vari-
ous parasites, and colonizing them parasite-free requires
special training beyond what is possible in most rural
Cambodian villages. The environment could have played
a role as Northern Vietnam (where programs were most
successful) has four distinct seasons and has different
flora and fauna. Additionally, many people did not
accept Mesocyclops to the same extent as other interven-
tions that were provided by the NDCP such as temephos
(personal communication, To Setha, 2015).
The search for other vector-control options continued
with an evaluation of Bacillus thuringiensis israelensis
(Bti), a Gram-positive, soil-dwelling bacterium used as a
biological control agent [18]. The evaluation of Bti in
Phnom Penh showed positive results with significant re-
ductions in the number of pupae for at least 2 and 2.5
months in containers with river and well-water, respect-
ively [18]. More extensive usage and evaluation of Bti by
the Cambodian government are currently occurring in
Kandal and Kampong Thom Provinces (personal com-
munication, Bunleng Sam, 2015).
Jar covers with long-lasting insecticidal netting (LN)
treated with deltamethrin were found to have signifi-
cantly fewer pupae per house, a three-fold decline in Ae.
aegypti adult females per house and adult mosquito
survival [20]. However, the magnitude of the reduction
diminished over time due to a gradual reduction of
insecticidal effect of the jar covers and a residual
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deltamethrin life of 22 weeks [20]. Interestingly, this is
less than the average residual life of deltamethrin in
treated bed nets [21]. Another cause may have been chil-
dren not always keeping the jar covering on after
extracting water, and using the covers as toys around the
house (personal communication to Setha, 2015) as Khun
et al. noted in Cambodia before [28]. Improvements in
engineering and design to prevent entry and egress of
mosquitoes, especially when the container is used, and
an increase the insecticidal effectiveness may be needed
for jar covers to be cost-effective public health interven-
tions [20].
The use of a larvivorous guppy fish (guppies) (Poecilia
reticulata) was evaluated in 14 Cambodian villages [21],
and subsequently in a larger study of 28 Cambodian vil-
lages [22]. Results from the initial study done from 2006
to 2007 were extremely encouraging with guppies in
56% of eligible containers, and a 79% reduction in Aedes
infestation compared to the control. Guppy fish are not
able to colonize all potential Aedes breeding sites, espe-
cially those which are polluted or with volume of less
than 50 L (personal communication to Setha, 2015).
However, despite not having guppies, the smaller or dis-
carded containers in the intervention villages had 51%
less infestation than those in the control, suggesting a
community-wide protective effect [21]. This could partly
be due to a spillover effect from treatment villages as no
results of guppy coverage were reported in the paper.
These results led the World Health Organization
(WHO) and the Asian Development Bank (ADB) to
fund a larger scale-up in 2010–2011 which included
Communication for Behavioral Impact (COMBI) activ-
ities. Results showed 88% guppy fish coverage in eligible
water containers and a Container Index (CI), i.e., pro-
portion of surveyed containers containing Ae. aegypti
larvae/pupae and indoor resting adult females of near 0
(while the control had a CI of 30) at the end of the pro-
ject [22]. Similarly encouraging results were found in
Laos as a part of the same project. However, there were
additional miscellaneous breeding sites including con-
tainers too small for guppy survival. Additional tools be-
yond larvivorous fish are required to target these varied,
hard-to-reach and cryptic breeding containers or sites.
One such alternative that has been evaluated in
Cambodia is pyriproxyfen (PPF) [16, 17]. PPF is a juven-
ile hormone analog that interferes with the metamor-
phosis of juvenile Aedes mosquitoes, preventing their
development into adults [29]. The results of the first
study in 2003 were so promising – at higher doses, in-
hibition of adult emergence (IE) greater than 87% for 6
months – that a larger second study was designed [16].
This showed that a novel 5% controlled-release forma-
tion led to IE above 90% for 20 weeks, and above 80%
for 34 weeks [17]. A slow-release PPF matrix release
formulation (Sumilarv® 2MR) has since been developed
and is suitable for containers uninhabitable by guppy
fish. The added benefit of this product is that it only
requires one distribution every 6 months (the entirety of
the rainy season) and cuts down on operational costs as
compared to temephos or Bti which have a residual
efficacy of 2–3 months [18, 30].
The effective implementation of Integrated Vector
Management requires mobilization and coordination of
the resources needed to achieve and sustain behavior
changes among populations at risk of dengue [31]. The
COMBI strategy provides a social mobilization and com-
munication approach that connects knowledge and be-
havior, addresses the cost and value of engaging in
healthy behaviors, recognizes the gradual stages of be-
havior change, and creates a supportive environment for
behavior change [32]. The challenge for vector control is
how community participation can be integrated into vec-
tor breeding-source reduction efforts [22]. Community
health workers (CHWs) are a vital part of successful
COMBI communication and social mobilization activities.
A recent review of 22 studies found that educational mes-
sages embedded in a community-based vector-control ap-
proach were effective at reducing Ae. aegypti measured
through entomological indices [33]. A separate systematic
review found that community-based control strategies in
addition or together with biological and chemical vector-
control tools reduced classical Aedes larval indices in five
of six field trials [34]. Two cluster randomized trials
published after the reviews showed that a community
empowerment strategy embedded in a routine dengue
vector-control program drastically reduced entomological
indices [35, 36]. These past studies show the importance
of having a strong community-based COMBI strategy,
and the important contribution that it can add when inte-
grated into the vector management strategy.
Need for a trial
Although there is evidence suggesting that the use of
guppy fish can be beneficial in dengue vector control,
recent reviews show that there has never been a cluster
randomized trial to evaluate their effectiveness to reduce
mosquito indices [37]. Although some studies have
evaluated the use of community-based communication
programs for dengue control, a recent review found that
none had assessed their costs [34]. This trial has the
potential to inform the strategic application of
community-based distribution of PPF and larvivorous
fish in an outbreak, during inter-epidemic periods or for
broad-scale application. This trial will also be the first to
our knowledge to evaluate the wide-scale use of the new
Sumilarv® 2MR product in the field (personal communi-
cation, John Lucas, 2015). Although guppies, PPF, and
COMBI activities have all been evaluated, some of these
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evaluations were methodologically flawed. Furthermore,
they have never been tested in combination. Therefore,
our study is intended to fill the knowledge gaps identi-
fied above.
Hypothesis
This trial aims to demonstrate community effectiveness of
guppies, PPF, and COMBI activities. The main hypotheses
are:
1. Use of guppies, Sumilarv® 2MR, and COMBI
activities will reduce numbers of Aedes mosquitoes,
and their infection rates, more than guppies and
COMBI alone, or usual Ministry of Health activities
(including larval control and information and
education material dissemination during outbreaks)
as assessed through entomology surveys
2. COMBI activities will improve the community’s
knowledge, attitudes, and behavior around water use
and vector-borne disease prevention (such as burning or
burying discarded containers, cleaning the environment
around the house, and sleeping under a bed net) as
assessed through baseline/endline surveys and Focus
Group Discussions (FGDs)
3. Guppies and PPF will be acceptable among the target
villages as assessed by an endline survey and FGDs
The study is designed as a cluster randomized con-
trolled, superiority trial with three parallel arms.
Methods/design
This protocol is reported following the Standard Proto-
col Items: Recommendations for Interventional Trials
(SPIRIT) criteria [38]. For the completed SPIRIT Check-
list see Additional file 1.
Study setting
The study has 30 clusters in two operational districts
(ODs) (one OD includes the jurisdiction of 10 health
centers (HC) or roughly 100,000–200,000 individuals)
within Kampong Cham province. Each cluster has on
average 200 HHs or 1000 individuals. The rainy season
runs from April to November, and the peak dengue sea-
son is from May to July. Kampong Cham was selected as
it has one of the highest dengue incidence rates of 1.6
cases per 1000 people in Cambodia and the environmen-
tal characteristics are similar to most dengue-endemic
areas of Cambodia (personal communication, Hai Ra,
2016). The clusters (containing one or more villages)
were selected based on availability of entomological sur-
veillance data from previous surveys. To avoid spillover
effects, clusters had to be at least 200 m from the
nearest HH outside the cluster since Ae. aegypti in this
region have an average flight range of 50–100 m [39]
(see Fig. 1).
Eligibility criteria
Every house within the cluster boundaries will be invited
to participate in the trial.
Fig. 1 Example of a 200-m boundary around selected clusters
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Interventions
Selected villages will be randomized into one of three
study arms (see Table 1). Study arm 1 receives all three
interventions, while study arm 2 receives only guppies
and COMBI activities, and arm 3 will receive only the
standard vector-control activities from the Ministry of
Health. The total trial period for the interventions will
be 11 months (see Figs. 2 and 3).
Study arm 1 was chosen to evaluate the effectiveness
of all three interventions in combination. Application of
any insecticide can be expensive when taking into
account procurement and operational costs. Arm 2 was
selected to evaluate the effectiveness of less expensive
interventions (guppies and COMBI), although all strat-
egies are expected to be less expensive than current
strategies. As COMBI-related activities have been shown
to have a significant impact on the coverage of interven-
tions in Cambodia and elsewhere [21, 22, 34] a guppy-
only arm was not included. Therefore, the trial will not
give separate estimates of the effects of guppies and
COMBI. Larvicide-only arms were not included because
larvivorous fish are more sustainable and cost-effective
than larviciding [16, 17, 21, 22, 40, 41], and if larviciding
was found to be equally effective, guppies would be rec-
ommended in terms of cost and acceptability.
Guppies
In rural Cambodia, more than 80% of Aedes mosquito
breeding is detected in key containers, such as large
water jars, cement tanks and other large containers, used
for the storage and collection of water for human and
animal consumption and washing [20]. To target these
containers, two guppy fish (Poecilia reticulata) will be
placed into each water container with a volume greater
than 50 L in intervention villages (arms 1 and 2). This is
based on larval consumption of guppies determined by
Seng et al. [21] and past experiences using guppies in
vector control in Cambodia [22]. The guppy fish will be
distributed after the baseline activities through a local
community network managed by provincial government
authorities. Guppy banks will be set up at the corre-
sponding health centers and consist of twenty 500-L jars.
Guppy banks will be colonized and can provide fish at
any time to CHWs in implementation villages. One
CHW will be assigned to monitor 30 HHs each month.
They will each have two 500-L jars which they can
colonize with guppies to provide for their assigned HHs.
When CHWs need more guppies they can return to the
guppy bank for them. Each month CHWs will conduct
visual checks and ensure that all their assigned HHs
have guppies in all large containers, and replace them if
necessary. Adult guppies are on average 1.5–3.5 cm long
(males) or 3–6 cm long (females) [42].
Pyriproxyfen matrix release (Sumilarv® 2MR)
Each device or disk (See Fig. 4) is designed to provide
coverage for 40 L of water. It is also possible to cut disks
into smaller sizes for smaller-sized containers (see
Table 2).
PPF devices will be distributed after the baseline
survey in the same manner as described above, and
replaced after 6 months. Additional devices will be left
at the health center for CHWs to distribute during their
monthly monitoring visit if some have been lost or need
to be replaced.
Although there have not been any studies evaluating
the safety of PPF in humans, toxicity to fish is induced
at 450 ppb, which is approximately 45 times greater than
the target ppb (10) of Sumilarv® 2MR [43]. The LD50 in
rats is 5,000,000 ppb, or 500,000 times the target con-
centration [44]. These data suggest a very favorable
mammalian toxicity profile, and extremely low risk for
humans using this product.
Communication for behavioral impact activities
An initial rapid assessment consisting of FGDs and In-
depth Interviews (IDIs) regarding knowledge, attitudes,
and behaviors of community members was completed.
The results were used in a message and material devel-
opment workshop held with key community and district
stakeholders. During this meeting the community helped
to develop behavior change communication materials
and come up with key messages. The results were used
to understand the common social gathering locations for
health education sessions, culturally appropriate chan-
nels of communication, and to create communication
materials: flip charts to guide CHW education sessions,
posters and banners for display in the villages, songs,
and CHW materials such as hats, t-shirts, bags, and rain
coats.
A 2-day training will be given to CHWs on communi-
cation and facilitation skills, following which they will
take the lead role in conducting health education ses-
sions in their community. A monthly meeting will also
be conducted with CHWs to assess progress, address is-
sues and challenges, and provide them with continuous
training to develop their confidence and skills. The
health education sessions will occur twice per month
and will be participatory, as Khun and Manderson [28]
found that health education sessions, where participants
Table 1 Interventions randomized to each study arm
Intervention Arm 1 Arm 2 Arm 3
Guppy fish in key containers (>50 L) X X
Communication for Behavior Impact
(COMBI) activities
X X
Direct pyriproxyfen (PPF) application
(Sumilarv® 2MR) in smaller containers (10–50 L)
X
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actively identify breeding sites and practice positive be-
haviors, can be more effective and less costly than the
didactic classroom-based sessions. In addition to health
education sessions, we will use locally available media,
such as loud speakers fixed to local transport, to play
songs, street theatre performances, and role playing to
reinforce the messages.
Adherence
In order to improve adherence to the intervention pro-
tocols, CHWs will perform monthly monitoring checks
on each HH within the intervention arms. The presence
or absence of guppy fish and PPF Sumilarv® 2MR in each
container within the HH will be recorded along with any
replacements the CHWs provide. The entomology sur-
veys will also record the presence or absence of each
intervention in containers (including those used for do-
mestic and non-domestic use) within the surveyed HHs.
Project staff will also randomly visit CHWs and inter-
vention HHs to confirm the reliability of data provided.
Primary outcome measures
The primary outcome measure is the population density
(i.e., number of mosquitoes per unit of time spent aspir-
ating) of adult female Aedes trapped using adult resting
collections.
Secondary outcome measures
The secondary outcomes for the trial include:
1. Dengue virus infection rate in adult female Aedes
mosquitoes
2. House Index (HI): proportion of houses surveyed
positive for Aedes larvae and/or pupae in any water
container
3. Container Index (CI): proportion of surveyed
containers containing Aedes larvae and/or pupae
4. Breteau Index (BI): number of containers positive
for Aedes larvae and/or pupae per 100 houses
surveyed
5. Pupae Per House (PPH): number of Aedes pupae per
household
6. Pupae Per Person (PPP): number of Aedes pupae per
person
7. Guppy fish coverage: proportion of eligible water
containers with at least one guppy fish
8. Sumilarv® 2MR coverage: proportion of eligible
water containers with at least one MR disk
9. Percentage of respondents with knowledge about
Aedes mosquitoes causing dengue
Sample size
The guppy fish and PPF interventions will be assessed
by an entomology survey. A sample size of 10 clusters
per arm and 40 HHs per cluster for the survey was de-
vised using the Hemming and Marsh method [45]. The
calculation assumed a mean of 0.1 adult female resting
Aedes mosquitoes per HH in the intervention arms
compared to 0.25 in the control arm for each collec-
tion. This assumption was based on the results from
the earlier World Health Organization/Asian Develop-
ment Bank guppy fish project in the same province
[22], and to be conservative assumed no impact from
the PPF in arm 1. The HHs will be randomly selected
at each collection. The intracluster correlation (ICC)
Fig. 2 Flow chart of cluster selection. Selection of clusters in Kampong Cham, Cambodia
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was assumed to be 0.01 based on previous studies [46–
48]. Additionally, a sensitivity analysis was conducted
up to the median value of ICCs for outcome variables
(0.03) as found by an analysis conducted by Campbell
et al. [49]. Our analysis determined that we would have
between 91 to 75% power at ICC values between 0.01
to 0.03. The coefficient of variation in cluster sample
size was assumed to be 0.1, and is expected be small as
we plan to sample the same number of houses from
each cluster. Under these assumptions the study will
have 91–75% power to detect a difference at the 5%
significance level.
COMBI activities will be evaluated through Know-
ledge, Attitudes, and Practice (KAP) surveys. A sample
size of 10 clusters per arm and 20 HHs per cluster was
devised, again using the Hemming and Marsh method
[45]. The calculation assumed a 22.5% change in primary
outcome indicators from 40 to 62.5% in intervention
villages and no change in the control villages over the
course of 1 year. Outcome indicators include:
Fig. 3 Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) with schedule of enrollment, interventions, and assessments
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1. Percentage of respondents with knowledge about
Aedes mosquitoes causing dengue
2. Percentage of HHs that keep guppy fish/PPF in
water
This calculation was based on the results from the
earlier projects done by Malaria Consortium (MC) in
the region, and a recent unpublished MC KAP survey
completed in six provinces and 30 villages in 2014. The
ICC was assumed to be 0.01, and the coefficient of vari-
ation of cluster size assumed to be 0.1. Under these as-
sumptions the study will have 90% power to detect a
difference at the 5% significance level.
Allocation
Clusters will be randomly assigned with a 1:1:1 alloca-
tion through a public randomization process. Village
chiefs from all clusters and HC chiefs from all HCs will
be invited to a central point along with local and na-
tional authorities. Locally, the concept of “lucky draw” is
very popular, so this method will be used to randomize
clusters. Each cluster representative will choose one
paper labeled either arm 1, 2, or 3 from a bowl. The
numbers on the papers will be printed and concealed by
folding the paper in half four times. Three large, labeled
sheets of paper will be put on the wall. As each repre-
sentative selected their study arm, MC staff will write
the cluster names on the corresponding sheet.
Data collection methods
Data will be collected at 0, 4, 8, and 12 months post
intervention, unless otherwise mentioned. The project
will employ the following methods:
Entomology
A baseline survey was conducted prior to start of inter-
ventions. An endline survey will be conducted 1 year after
the baseline. Two additional surveys during the dry season
(4 months post intervention) and light rain (8 months
post intervention – peak dengue season) will also be con-
ducted. The schedule of the surveys took into account
data from the previous guppy fish project [22]. The survey
methodology was developed following the WHO guide-
lines for entomological collections [1]. Surveys will include
indoor adult resting catches and larvae/pupae collection
from water containers. The survey team consisted of expe-
rienced government staff who received 3 days’ training be-
fore beginning. All tools and materials were pre-tested
during training. The same team will be used for each ento-
mology survey. Houses within each cluster were selected
using a random-number generator [50] applied to the vil-
lage list managed by the village head.
The adult resting catch will be completed using a
battery-powered, portable aspirator (Camtech, Phnom
Penh, Cambodia) for 10 min per house in the bedrooms
and living spaces, starting in the bedroom and aspirating
up and down the wall (from floor to 1.5 m) around the
home in a clockwise manner. The mosquitoes will be
kept in a screw-top containers inside a cold box and
transported to the provincial laboratory for identification
to the species level for Aedes, otherwise to genus. All Ae-
des mosquitoes will be sexed. After identification they
will be stored in a −20 °C freezer and taken to the
United States Naval Medical Research Unit 2 (NAMRU-
2) in Phnom Penh for confirmation. All Aedes females
will be pooled and subjected to flavivirus rRT-PCR
screening [51]. Flavivirus-positive pools will be further
tested for dengue typing by semi-nested RT-PCR assay
targeting the C and pre-M regions within the viral gen-
ome [52].
Larvae and pupae collection will be completed using
the five-sweep net method [53] for containers larger
than 50 L. The size of the net is 20 cm by 33 cm. Sur-
veyors will turn the net in an anti-clockwise manner five
times, then wait 1 min and perform one sweep from the
bottom. This method can sample around 35% of larvae
and 31% of pupae, and the total number estimated by an
Fig. 4 Sumilarv® 2MR disk (5-cm radius)
Table 2 Dosage application rate of Sumilarv® 2MR disks (target
dosage is one disk per 40 L)
Container capacity, L Number of 2MR disks Target ppb
10 1/5 27
20 ½ 27
30 2/3 27
40 1 27
50 1 27
ppb parts per billion
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adjustment factor [53]. For containers of less than 50 L,
all the water will be poured through the sweep net. All
containers within selected HHs will be inspected. All
pupae and 10 larvae per container will be put in a plastic
bag, labeled (with date and code), and taken back to the
laboratory for identification to the species level for Ae-
des, otherwise to genus. After identification they will be
taken to NAMRU-2 in Phnom Penh where entomolo-
gists will confirm identification of a random sample of
50% of immature mosquitoes.
Survey teams will also record the number, size, and
type of all water containers in the HH The team will
complete a rapid assessment tool (Premise Condition
Index; PCI) [54] to identify whether the scores can pre-
dict HH risk for Ae. aegypti infestation. If proven useful
as an indicator of risk, PCI could be used to streamline
future surveys and program activities and possibly
reduce program costs.
Knowledge, attitudes, and practices
The KAP survey was designed around the results of the
FGDs and IDIs to create questions based on the local
context and language [55]. The KAP will be pilot tested
in a neighboring community, and revised where neces-
sary. Questions are close ended or are categorized by
data collectors at the time of response.
KAP surveys will be conducted at the same time as
baseline and endline entomology surveys. Only the HH
head will be asked to respond. The data will be collected
by experienced government staff who will be given 2
days’ training before implementation. Each team will
have a supervisor who can monitor data integrity and
quality. All paper forms are submitted to the MC super-
visor who performs a final check making sure that all
questions receive a response and that skip patterns are
followed correctly.
Community health worker monthly monitoring
The coverage of guppy fish and PPF Sumilarv® 2MR will
be assessed by ocular inspection of water containers via
entomology surveys and the CHW monthly reporting
form as described in the adherence section. Coverage is
expressed as percentage of containers with guppy fish or
Sumilarv® 2MR of the total HHs or containers examined.
Location
The geographical location of each village within the trial
and all HHs in the entomology/KAP surveys will be re-
corded by a handheld Global Positioning System and
plotted using ArcGIS® version 10 (Environmental System
Research Institute, Redlands, CA, USA) for spatial ana-
lysis and for presentation purposes.
Climate
General climate data (rainfall, temperature and humidity)
will be recorded at one of the intervention health centers
using a rain gauge and a Hobo onset data logger (all vil-
lages have virtually the same climate). Data from the all
United States National Aeronautics and Space Adminis-
tration (NASA) satellites on climate will also be available
including air pressure, air temperature, atmospheric mois-
ture, evaporation, precipitation, and wind [56].
Data management
Double data entry into EpiData (EpiData Association,
Odense, Denmark) is completed by an experienced data-
entry company. The process of data cleaning is being
handled by MC staff. The original forms are kept in a se-
cure, locked cabinet in the MC Phnom Penh office, and
will be available during data cleaning and analysis. Sur-
veys will be maintained in storage for a period of 2 years
after completion of the study.
Statistical methods
All statistics will be performed in R (Murray Hill, NJ,
USA) and Stata® (College Station, TX, USA).
Primary outcome
Adult female Aedes density will be summed over follow-
up time points to give a single rate per cluster. This will
be analyzed by negative binomial regression using the
number of adults as the response, and the logarithm of
the sampling effort (that is, person-time spent aspirat-
ing) as an offset. Hence, this analysis will yield density
ratios. The primary analysis will not be adjusted, but sec-
ondary analysis will include an analysis adjusted for the
baseline density.
Secondary outcomes
Secondary outcomes including entomological indices,
such as HI, CI, BI, PPH, and PPP and dengue viral in-
fectivity rate, will also be analyzed by the above
methods.
Missing data
Missing data will be reported as recommended by Díaz-
Ordaz et al. [57] and their impact may be explored in
secondary analyses.
Data monitoring
In accordance with the findings of Grant et al., we have
not established a Data Safety Monitoring Board for this
study as it is not a “clinical trial evaluating a therapy
with a mortality or irreversible morbidity endpoint” [58].
However, a Technical Steering Committee (TSC) was
established which will meet at least every 6 months and
address any safety or other concerns that may arise. The
Hustedt et al. Trials  (2017) 18:367 Page 9 of 13
TSC will have one member from each of the partner or-
ganizations including the government and WHO. HC
and CHW staff have been advised to contact MC staff
should any adverse event be detected through passive
monitoring as a result of project activities. CHW
monthly monitoring forms will also record any adverse
events (such as tingling in the hands after touching PPF
or gastrointestinal effects after potential exposure of PPF
to the mouth) that are reported. Any event will be
promptly reported to the ethics committees and govern-
ment partners. If an end to the trial is needed, the deci-
sion will come from the chair of the TSC. However, no
harms are foreseen, and trials of similar products have
not experienced any adverse events or unintended
effects [16, 17].
Access to data
All co-principal investigators and partners will be given
access to the cleaned datasets without identifiers, which
will be stored on the Malaria Consortium Sharepoint
site and will be password protected. The final dataset
will also be stored in the Cambodian National Center
for Parasitology, Entomology, and Malaria Control cen-
tral repository.
Ancillary and post-trial care
In the event of any harm associated with the protocol
MC will be responsible as the trial sponsor. The control
group will be receiving routine interventions from CNM
as described above and will continue to receive them
after the close of the project. After the end of the project
the lead institution, MC, will continue to advocate for,
and encourage uptake of, any policy recommendations
that come from the study.
Dissemination policy
The principal investigator (Jeffrey Hii) will ensure that
the results of the trial are published regardless of out-
come. At least every 6 months results will be shared
with the Technical Steering Committee. In addition to
reporting the results in peer-reviewed journals, the
results will disseminated at the provincial level and
national level to all project stakeholders. All documents
and study materials will be made available in a tool kit
that will be given to all government stakeholders and part-
ners. The investigators will also disseminate their findings
in international scientific conferences. Reporting will fol-
low the guidelines in the Consolidated Standards of
Reporting Trials (CONSORT) Statement [59]. Authorship
will follow MC authorship guidelines which require sub-
stantive contributions to the design, conduct, interpret-
ation, and reporting of a trial. The full protocol,
household-level dataset, and statistical code will placed in
the Cambodian Ministry of Health’s central repository
within 6 months of completion where all interested re-
searchers can request access.
Discussion
Due to the rise in dengue cases [3] and the current lack
of effective vaccines and therapeutics, there is an urgent
need to develop more effective vector-control methods
[22]. These methods together with the development of
new vaccines [12], genetic control of mosquitoes [14,
15], and new therapeutic drugs [60] will be essential in
reducing dengue prevalence throughout the world. Add-
itionally, evidence suggests that the main vector-control
tool in Cambodia (temephos) is becoming less effective
[19, 20], and a need to assess new sustainable vector-
control methods in this context exists [22].
Recent studies have suggested the use of larvivorous
fish to be effective in vector control [21, 22]; however,
many were methodologically flawed and none have used
a randomized controlled design [37]. The studies on pre-
vious products similar to Sumilarv® 2MR showed posi-
tive results [16, 17]; however, the new product has not
been tested externally beyond small ongoing semi-field
trials in Thailand (personal communication, Muney
Serit, 2015). Evidence from larger trials is essential when
trying to understand the true impact of these vector-
control tools and in making recommendations to gov-
ernment bodies and donors.
The study area is suitable for the current trial as the
disease is prevalent in the selected districts, and the
province has a history of dengue outbreaks [20]. The
study team is also familiar with the area having con-
ducted multiple dengue research projects in the area,
and have good relationships with the local authorities
and communities in the area.
It would be preferable to have a primary outcome dir-
ectly related to dengue incidence rather than an entomo-
logical one. Finding the appropriate metric to measure
disease impact is bedeviled by the effect of human move-
ment on patterns of transmission, and the pronounced
temporal and spatial heterogeneity in transmission, which
will necessitate very large cluster randomized study de-
signs. We considered passive surveillance for dengue with
rapid diagnostic tests in HCs. Although sensitivity among
currently available tests was considered acceptable for
routine clinical diagnostics [61] it was not considered high
enough for seroconversion studies. No studies had used
rapid diagnostics to estimate seroprevalence. Therefore,
more expensive and labor-intensive efforts were prefera-
ble, such as cohort studies or capture-recapture methods
(which have their own limitations [62]) to estimate the
true number of cases, and using a more sensitive diagnos-
tic tool such as RT-PCR. However, due to budget limita-
tions it was not possible to employ them. Additionally,
unpublished data from a recent cohort study in the
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proposed districts suggest that, given similar number of
cases during this study timeframe, and the resources avail-
able to the current project, there would not be enough
statistical power to show an impact of the likely size on
case numbers. (personal communication, Agus Rachmat,
2015). Therefore, the endpoint chosen was the density of
adult Aedes mosquitoes, which are on the causal pathway
to disease.
There is always a need to balance potential benefits
and harms during a trial. The potential benefits of the
trial are substantial, and trials of similar interventions in
the past have not experienced any adverse events or un-
intended effects [16, 17, 21, 22]. Additionally, because of
the low acute toxicity of PPF it is considered extremely
safe and is recommended by the WHO for use in drink-
ing water [44].
This trial is designed to measure the reduction in adult
and juvenile mosquitoes due to these vector-control
methods relative to a control. However, one limitation is
that the study was powered to detect a statistically sig-
nificant difference between each arm compared with the
control, and not between the intervention arms. This re-
duces the ability to see the impact of the PPF. A possible
source of bias may be not having data collectors blind to
the intervention; however, in this case it is unavoidable
as data collection teams will be able to see the interven-
tions in the containers which they sample. Contamin-
ation (spillover) of COMBI activities from intervention
villages could affect our study by increasing knowledge
or use of guppy fish in control areas. However, in the
previous study it was found that only about 5% of con-
tainers had guppies in the control area at the end of the
project [22]. Measurements of guppy fish coverage will
also be conducted in control villages to identify the ex-
tent of any contamination.
Although these data are being collected within one prov-
ince in Cambodia, it is likely that the result of this trial
could be generalizable to areas with similar ecology within
the country and in neighboring countries. Each country or
province will have to make its own decision based on indi-
vidual contexts. For example, unpublished MC studies in
Myanmar showed similar size and types of containers and
community practices in two regions, and interest from gov-
ernment officials in introducing guppies to water containers
in response to dengue outbreaks (personal communication,
Jeffrey Hii, 2015). However, the decision was made to not
introduce guppies in the Philippines as the community ac-
ceptance was low and the cool climate in higher altitudes
was not suitable for guppy survival and reproduction (per-
sonal communication, Jeffrey Hii, 2015).
Trial status
At the time of submission of this manuscript the trial
had completed the baseline data collections, enrollment
of villages, and randomized allocation of the villages to
three study arms.
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